Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN002193 | 41.00299759 | 27.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 41.03964842 | 26.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 41.9978012 | 666 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 41.99857277 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 42.99559728 | 25.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 43.01826191 | 852.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 43.0190078 | 25.7 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 44.99780878 | 941.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 44.99784168 | 20.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 46.00085378 | 778.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 46.00098359 | 942.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 46.00118858 | 21.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 47.00291705 | 24.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 47.96732087 | 36.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 55.01931156 | 25.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 56.94296747 | 19.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 56.96332398 | 19.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 56.99861962 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 57.03497356 | 25.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 57.96160705 | 19.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 58.95870908 | 963.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 58.95873127 | 19.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 59.01346411 | 845.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 59.01410998 | 25.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 61.98878291 | 24.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 62.96443009 | 27.66 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 62.988624 | 952.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 62.99151209 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 64.94551465 | 953.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 67.01928506 | 27.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 68.9959359 | 28.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 69.03449295 | 38.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 70.99875423 | 947.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 71.0135087 | 785.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 71.01444915 | 25.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 71.05012512 | 42.94 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 72.99371367 | 25.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 73.01154807 | 150.52 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 73.02938579 | 282.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 73.02985404 | 27.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 74.02534494 | 25.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 74.03263573 | 282.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 74.93846923 | 946.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 74.99064384 | 417.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 75.00943014 | 25.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 77.0396016 | 71.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 77.96550314 | 37.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 78.91879372 | 948.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 78.91942062 | 24.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 78.95960735 | 27.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 79.95721032 | 241.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 79.95733273 | 955.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 79.95733681 | 103.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 79.95744929 | 50.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 80.91674875 | 949.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 80.91735614 | 24.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 80.96514195 | 53.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 80.9735249 | 982.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 81.03440841 | 46.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 81.04619015 | 23.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 81.95323157 | 50.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 81.95326974 | 102.84 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 82.03033191 | 26.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 82.95498057 | 25.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 82.9960187 | 45.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 83.01458179 | 24.94 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 83.0502377 | 46.66 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 84.04591718 | 26.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 84.95192381 | 25.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 84.98569179 | 957.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 84.98712408 | 872.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 84.9892617 | 70.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 85.02983441 | 34.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 85.92986898 | 19.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 85.92993892 | 962.15 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 86.03339455 | 26.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 86.94960469 | 792.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 86.9497359 | 947.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 86.97609287 | 631.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 87.00946397 | 25.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 87.04520469 | 47.11 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 87.92523725 | 997.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 87.92526273 | 19.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 88.01241745 | 25.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 88.0410697 | 24.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 88.04845927 | 47.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 88.9452252 | 947.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 89.02435559 | 843.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 89.024965 | 26.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 89.92566474 | 798.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 89.92571185 | 947.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 89.92572613 | 19.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.0283487 | 27.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.90412839 | 21.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.93340321 | 793.05 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.93348961 | 19.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.93353604 | 945.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.98576397 | 236.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 90.98579223 | 64.11 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.00285148 | 352.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.00286017 | 961.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.00306337 | 556.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.02186503 | 584.84 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.02196821 | 707.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.02198958 | 417.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.02863201 | 32.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.92124287 | 947.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.92127331 | 19.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 91.95704151 | 417.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 92.02363695 | 417.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 92.02519006 | 770.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 92.05047965 | 41.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 92.92857245 | 23.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 92.92897263 | 947.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.00118014 | 417.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.01898396 | 417.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.03452327 | 234.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.03453137 | 184.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.03464185 | 49.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.04567275 | 25.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.91868255 | 946.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.92862962 | 19.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 93.92864846 | 946.92 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.03114606 | 32.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.92100555 | 956.1 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.92558727 | 23.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.9264872 | 946.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.98082819 | 766.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.98086712 | 950.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 94.98114061 | 25.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 95.01373051 | 955.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 95.01388339 | 38.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 95.05018968 | 64.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 95.92012692 | 947.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.00895096 | 729.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.02064486 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.04555312 | 39.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.91869841 | 956.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.92172225 | 532.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.92193986 | 359.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.92258869 | 23.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.9260967 | 946.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.96021565 | 950.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 96.96176555 | 47.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 97.93091379 | 19.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 97.93123446 | 896.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 97.95941277 | 733.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 97.9605265 | 63.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 97.97470606 | 27.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.02572768 | 25.22 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.90675811 | 19.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.90686344 | 950.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.93912871 | 849.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.93917354 | 932.84 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.95682611 | 40.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 98.97429279 | 27.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 99.00872981 | 691.94 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 99.00973824 | 25.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 99.04522351 | 44.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 99.92573827 | 19.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 99.9258662 | 854.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.0039649 | 207.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.0040574 | 39.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.0417842 | 26.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.077186 | 26.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.9044925 | 19.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.9052511 | 954.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.9329137 | 19.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.9335378 | 857.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.9527639 | 963.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 100.9533451 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.006858 | 40.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.0251235 | 25.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.06111 | 48.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.9251153 | 19.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.9337636 | 849.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.9337809 | 948.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.9405166 | 963.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 101.9516891 | 19.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.0346321 | 71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.0567671 | 25.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.9324489 | 58.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.9332397 | 946.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.9487179 | 1058.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.9489959 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.9546368 | 570.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 102.9746428 | 47.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 103.0043776 | 25.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 2-Hydroxybutyrate | 103.0395 | 0.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 103.0403366 | 36.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 103.9201782 | 1031.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 103.9202804 | 19.84 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 103.9366124 | 948.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 103.949936 | 21.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 104.0361367 | 24.15 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 104.9279516 | 961.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 104.9280517 | 19.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 104.9539248 | 22.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 104.9852053 | 946.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 105.0015174 | 37.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 105.020092 | 24.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 105.9224635 | 947.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 105.9349559 | 19.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 106.0422464 | 72.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 106.0659772 | 269.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 106.9274469 | 947.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 106.9428957 | 960.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 106.9811679 | 947.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 106.9815465 | 24.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 107.0252465 | 71.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 107.0500448 | 184.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 107.0502134 | 102.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 107.9164299 | 946.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.0216006 | 52.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.0461657 | 25.7 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.0535725 | 103.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.8995623 | 948.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.9023978 | 23.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.9254204 | 947.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.9256739 | 771.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.9355444 | 954.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 108.988508 | 19.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 109.0295153 | 43.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 109.0405332 | 72.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 109.9080747 | 948.84 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.0326241 | 42.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.0722846 | 21.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.8958317 | 948.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.8995585 | 23.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.9154091 | 953.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.9370953 | 954.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.9584828 | 25.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.9758137 | 949.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 110.9763406 | 25.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.0003063 | 884.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.0095673 | 27.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.0450956 | 42.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.0813326 | 76.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.0814259 | 199.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.9034553 | 948.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.947099 | 103.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 111.9472267 | 51.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.0133013 | 27.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.0517276 | 21.66 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.0763889 | 53.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.8923577 | 948.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.8968311 | 23.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.9395327 | 956.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.9855082 | 566.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.9855253 | 765.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.9855469 | 365.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.9856004 | 942.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 112.9857358 | 20.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0151438 | 25.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0240238 | 41.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0241922 | 278.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0242381 | 146.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0243724 | 342.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0605884 | 136.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0606788 | 66.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.0970854 | 252 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.9261796 | 19.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.9262891 | 858.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.987419 | 957.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.9887007 | 718.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.9888061 | 297.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 113.9890583 | 20.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.019215 | 524.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.0204366 | 25.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.0569143 | 37.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.0923293 | 38.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.9338444 | 53.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.9339664 | 899.94 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.9892873 | 946.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.9893389 | 275.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 114.9894523 | 20.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.0005906 | 580.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.0047624 | 25.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.0183548 | 25.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.0401532 | 42.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.0762777 | 190.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.0763149 | 88.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.9205893 | 19.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.9209842 | 844.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 115.9212385 | 948.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.017536 | 37.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.0364971 | 25.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.0499093 | 45.1 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.0501723 | 214.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.071657 | 47.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.9264918 | 845.26 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.9283408 | 1033.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 116.9865353 | 298.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.000398 | 963.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.0194989 | 35.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.0557103 | 50.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.0707844 | 272.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.9202148 | 20.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.9251699 | 948.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.928841 | 958.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 117.9732476 | 955.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.0235821 | 27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.0581277 | 38.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.4746836 | 955.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.8998517 | 951.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.9260478 | 619.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.9273663 | 408.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.9275548 | 237.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.928258 | 951.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.930621 | 22.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.9702589 | 702.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.971762 | 956.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 118.9920825 | 949.37 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 119.4731839 | 955.5 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 119.9150318 | 1101.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 119.9150576 | 1014.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 119.9151184 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 119.9283534 | 948.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 119.9473427 | 23.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.0130526 | 25.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.039457 | 25.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.0959974 | 828.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.8974592 | 951.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.8992184 | 22.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.9159111 | 19.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.9159521 | 961.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.9283857 | 22.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 120.9972089 | 25.72 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.0296397 | 53.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.029836 | 229.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.0319537 | 609.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.0406602 | 25.1 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.0656076 | 178 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.8976282 | 949.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.9183488 | 963.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.9185739 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 121.9444717 | 23.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 122.0325707 | 53.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 122.0610488 | 44.7 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 122.8940725 | 1013.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 122.8944184 | 22.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 122.9055522 | 723.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 122.976411 | 25.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.0088524 | 38.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.0119038 | 786.15 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.0120519 | 950.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.0451946 | 47.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.0813245 | 210.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.8776495 | 29.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.9014283 | 724.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.90169 | 21.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.901832 | 959.72 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 123.946229 | 19.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.0084299 | 24.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.0405165 | 39.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.0486969 | 47.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.0634114 | 21.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.8918364 | 182.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.8929138 | 22.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.8943618 | 948.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.95471 | 53.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 124.9921167 | 24.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.0245721 | 38.66 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.0605012 | 67.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.0606147 | 181.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.097063 | 249.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.8735516 | 29.22 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.8983772 | 22.22 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.898669 | 955.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.9353955 | 804.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 125.9706473 | 956.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.0202463 | 25.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.0304007 | 997.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.0306374 | 37.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.056367 | 26.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.1003242 | 249.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.881013 | 1088.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.8819109 | 22.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.9043949 | 949.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.9045852 | 801.66 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.9054239 | 25.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 126.9864942 | 44.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0399622 | 59.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0508143 | 195.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0512073 | 72.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0516928 | 24.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0762083 | 216 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0763345 | 150.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0763464 | 47.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.0763486 | 845.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.1124466 | 327.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.8707468 | 29.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.8711657 | 306.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 127.8743027 | 950.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.0355467 | 34.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.0524547 | 95.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.8779204 | 1085.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.8786892 | 22.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.8867991 | 948.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.9328095 | 26.67 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 128.9596697 | 21.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 2-Methylmaleate/Itaconate | 129.0188 | 0.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 129.0191866 | 887.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.0195612 | 36.52 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 3-Methyl-2-Oxovalerate | 129.0549 | 1.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 129.0554309 | 170.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.0554579 | 71.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.0917842 | 199.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.8701905 | 22.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.8705706 | 950.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.9356803 | 854.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.9358677 | 304.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.9360208 | 956.15 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.9363277 | 19.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 129.9756734 | 22.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.0233864 | 26.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.0529351 | 25.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.0660334 | 217.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.087042 | 119.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.0871828 | 37.37 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.8762238 | 22.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.8815883 | 949.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9289127 | 930.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9289144 | 845.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9656389 | 951.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9660621 | 16.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.991646 | 1088.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9922282 | 418.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9923128 | 911.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 130.9926437 | 26.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Ethylmalonate | 131.0341 | 0.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 131.0349597 | 856.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.0350491 | 41.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.0458922 | 23.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.0697136 | 217.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.0712657 | 52.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.8667345 | 22.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.8671507 | 950.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.9148506 | 593.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.9151327 | 19.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.9155033 | 931.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.9705059 | 954.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 131.9898936 | 861.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.0311481 | 25.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.0451379 | 70.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.0672319 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.8677579 | 950.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.868081 | 22.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.9233175 | 19.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.9233707 | 852.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.9469961 | 26.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.9674638 | 25.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 132.98867 | 679.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.0148702 | 26.11 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.0291968 | 58.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.0507904 | 36.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.0656594 | 272.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.0765894 | 21.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.9062781 | 968.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.9234911 | 869.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 133.9919615 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.0371724 | 58.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.0471137 | 22.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.0604389 | 70.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.0689742 | 272.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.079945 | 22.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.8655156 | 22.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.8658062 | 950.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.8943671 | 950.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.8950218 | 24.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.9162523 | 21.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.9233223 | 949.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.9441297 | 26.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.9872622 | 954.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 134.9878148 | 19.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.0083823 | 86.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.0307291 | 24.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.044407 | 157.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.0452266 | 417.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.0554935 | 47.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.0643915 | 71.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.0811884 | 220.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.8961842 | 951.22 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.9019112 | 961.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.9022223 | 28.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.9029211 | 627.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.9261134 | 949.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.9462054 | 19.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 135.971672 | 948.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.0164697 | 53.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.0342643 | 25.05 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.0523812 | 86.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.066905 | 71.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8630522 | 22.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8636997 | 1112.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8639175 | 251.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8652901 | 950.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8917784 | 522.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8919393 | 26.22 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.8923332 | 874.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.892425 | 950.05 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9095743 | 1047.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9098959 | 21.52 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9181784 | 25.72 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9192252 | 946.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9733952 | 947.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9836127 | 20.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 136.9909025 | 949.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 3-Hydroxybenzoate | 137.0234 | 1.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | Salicylate | 137.0235 | 3.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 4-Hydroxybenzoate | 137.0236 | 1.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 137.0242934 | 234.18 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.0245555 | 871.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.02485 | 39.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.0603709 | 191.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.0606647 | 57.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.0969395 | 263.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.8727377 | 951.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.8987804 | 957.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.9087475 | 948.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.9102123 | 21.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.9403285 | 27.26 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 137.9904251 | 695.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.0197275 | 111.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.0198183 | 208.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.0199273 | 594.05 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.020288 | 923.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.0213834 | 25.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.0300059 | 84.67 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.0564964 | 37.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.8602714 | 22.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.8691906 | 951.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.8752547 | 23.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.8907008 | 948.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.9064328 | 527.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.9066518 | 1012.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.9070451 | 21.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.971579 | 25.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.9720779 | 954.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.977437 | 244.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 138.9814881 | 53.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.00687 | 488.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0068856 | 369.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0069131 | 589.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0069844 | 775.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0070865 | 920.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.007239 | 37.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0397812 | 63.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0579977 | 25.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.0759792 | 209.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.1125256 | 259.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.872754 | 22.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 139.9712561 | 27.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.0099971 | 950.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.0113068 | 25.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.0352368 | 38.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.8687 | 951.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.8983981 | 21.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.8997157 | 808.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.8997816 | 947.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.9178882 | 27.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.9799362 | 788.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.9817068 | 640.26 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.9836118 | 301.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 140.9856035 | 25.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.0014166 | 47.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.003889 | 805.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.0039913 | 949.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.0192916 | 38.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.0554569 | 51.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.0672874 | 25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.091939 | 224.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.8678483 | 1079.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.8682065 | 22.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.9126009 | 22.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.9360306 | 863.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 141.9647941 | 899.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0082131 | 947.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0101897 | 781.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0127588 | 22.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0129348 | 613.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0322547 | 50.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0512198 | 36.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.06577 | 45.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.06598 | 207.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.0951302 | 223.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.8680678 | 950.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.8749693 | 22.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.897922 | 819.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.8979291 | 948.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.9290686 | 952.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.9452459 | 1084.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.9806083 | 37.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 142.9960057 | 899.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Maleate | 142.9988 | 0.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 142.9994712 | 24.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.0351367 | 37.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.0462707 | 23.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.0497844 | 289.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.049939 | 221.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.0700838 | 208.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.0708391 | 531.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.0712814 | 47.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.1073447 | 375.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.1074722 | 250.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.8649612 | 1092.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.8654461 | 22.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.8681897 | 950.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.8982707 | 31.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.8987019 | 947.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.9093338 | 22.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.9352961 | 961 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.9354247 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.9513779 | 873.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 143.988147 | 948.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.0030656 | 24.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.0310521 | 25.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.0452264 | 204.5 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.045336 | 61.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.0668941 | 36.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.0742323 | 47.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.102779 | 223.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.8664312 | 949.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.8708291 | 24.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.8975352 | 805.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.8977307 | 947.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.9232473 | 952.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.9232577 | 19.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.942753 | 996.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.9430598 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.967866 | 25.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 144.9911788 | 871.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.015038 | 25.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 2-Methylglutarate | 145.0498 | 0.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 3-Methylglutarate/Adipate | 145.05 | 0.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 145.0504446 | 864.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.0609465 | 195.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.0615579 | 47.05 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.0866506 | 180.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.0868581 | 262.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.0979585 | 23.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.8631067 | 22.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.8648315 | 950.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.8988522 | 818.67 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.8989198 | 947.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.9308258 | 961.11 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.9330889 | 19.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.9351938 | 948.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.993755 | 924.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 145.9987779 | 22.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.0242733 | 70.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.0467071 | 25.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 3-Methyl-2-Oxindole | 146.0601 | 0.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 146.0608644 | 71.52 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.0818731 | 38.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.8674708 | 24.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.8984692 | 947.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9232118 | 946.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9384169 | 1063.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9386097 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9614741 | 607.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9640954 | 951.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9661809 | 24.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 146.9833425 | 27.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.0304006 | 36.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.0445929 | 225.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.0663105 | 37.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.1176484 | 282.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.8615158 | 950.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.8616652 | 22.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.8920745 | 970.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.8921369 | 19.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9074596 | 24.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9262447 | 947.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9392 | 962.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9392769 | 560.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9397814 | 359.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9401092 | 195.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9405042 | 1038.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.940619 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 147.9825989 | 960.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.0398225 | 44.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.0526353 | 226.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.0691281 | 37.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.0764597 | 115.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.0765134 | 179.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.8643139 | 24.73 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9003981 | 835.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9171443 | 512.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9185721 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9186135 | 946.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9375346 | 782.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9377093 | 947.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.940095 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.9739638 | 31.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 148.991107 | 37.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0091698 | 618.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0092164 | 711.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0093244 | 464.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.009386 | 28.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0245145 | 47.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 2-Hydroxy-4-(Methylthio)Butanoate | 149.0252 | 0.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 149.0461721 | 25.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0601637 | 226.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0714357 | 40.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.0968377 | 282.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.8971628 | 976.67 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.904902 | 24.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.9201051 | 947.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.9246301 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.9367138 | 774.31 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.994867 | 827.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 149.9973919 | 957.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.009813 | 464.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.0241517 | 24.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.0557923 | 38.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.0558879 | 124.03 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.8872953 | 23.37 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.8892186 | 257.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.8895449 | 951.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.9157702 | 19.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.9336767 | 790.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.9337701 | 946.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.9828258 | 956.7 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 150.9880639 | 36.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.0060277 | 948.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.0078106 | 25.15 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | P-Hydroxyphenylacetate/2-Hydroxyphenylacetate | 151.0392 | 1.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | Guaiacol | 151.0394 | 1.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 151.0398626 | 71.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.039906 | 184.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.0591559 | 123.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.0609685 | 22.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.076148 | 243.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.1124974 | 285.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.8756758 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.8898621 | 951.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.9191178 | 30.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.9203811 | 974.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.9204259 | 555.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.936154 | 946.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.9371514 | 795.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.9966245 | 571.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 151.9968851 | 895.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.0113352 | 39.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.035344 | 283.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.0354688 | 791.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.0359501 | 47.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 3-hydroxyanthranilic acid | 152.0362 | 0.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 152.0433469 | 184.53 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.0615185 | 124.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.0819698 | 22.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.8841749 | 23.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.8868585 | 952.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.9041634 | 31.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.9250644 | 954.29 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.9783979 | 19.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.981687 | 676.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.985626 | 951.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.9949975 | 25.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.9954731 | 423.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 152.9956144 | 231.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.0192753 | 67.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.0226021 | 949.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.0227666 | 660.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.0312491 | 25.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.0552017 | 132.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.0555835 | 38.05 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.091908 | 243.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.868568 | 950.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.8693821 | 25.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.9003012 | 23.72 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.9676018 | 25.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 153.9918176 | 854.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.0158603 | 62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.0334626 | 24.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.0622412 | 21.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.0869476 | 87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.0950412 | 243.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.8813039 | 23.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.8993001 | 28.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9021511 | 950.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9288781 | 26.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9289161 | 954.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9470954 | 592.26 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9473876 | 24.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9665821 | 953.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9738905 | 20.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 154.9993032 | 36.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.0014091 | 949.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.0348122 | 72.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.0469414 | 24.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.0704533 | 822.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.0709724 | 134.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.071066 | 245.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.1075364 | 269.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.8661456 | 951.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.866986 | 25.1 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.8866082 | 946.95 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.8873414 | 23.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.9468597 | 24.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 155.9887877 | 955.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.0312226 | 25.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.0665818 | 53.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.1107641 | 269.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.4901614 | 954.92 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.8660555 | 950.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.877868 | 23.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.8945483 | 783.5 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.8945643 | 947.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.9260233 | 26.34 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.944973 | 1037.85 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.9478464 | 32.5 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.9809214 | 869.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.9949965 | 959.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 156.9963946 | 38.7 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0135756 | 27.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0368222 | 24.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0496759 | 955.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Sorbate | 157.0499 | 1.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 157.05033 | 170.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0503504 | 550.32 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.050477 | 54.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0771035 | 36.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0867587 | 288.22 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0867596 | 111.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.0868215 | 202.07 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.123048 | 272.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.1231083 | 409.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.8630048 | 951.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.8633433 | 28.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.8850811 | 904.17 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.9308637 | 804.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.931374 | 19.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 157.9846604 | 949.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.0370541 | 279.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.0470921 | 26.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.0821443 | 61.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.1184115 | 296.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.8471755 | 24.01 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.8922119 | 947.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.9258369 | 27.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.9344523 | 957.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.9754469 | 858.38 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 158.9783604 | 19.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.0107099 | 40.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Oxoadipate | 159.0294 | 0.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 159.0308177 | 25.79 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 6-Carboxyhexanoate | 159.0656 | 1.51 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 159.0661171 | 88.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.0666879 | 37.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.0805957 | 283.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.0854994 | 63.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.1024257 | 205.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.1024394 | 308.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.5223717 | 863.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.8455745 | 23.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.8589136 | 951.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.8602511 | 29.27 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.8784599 | 22.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.8932055 | 783.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.8932736 | 947.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.9460016 | 953.63 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.9462287 | 752.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.9466193 | 19.19 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.976713 | 848.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.9769224 | 949.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 159.9797636 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Indole-3-Carboxylic acid | 160.0395 | 3.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 160.0400776 | 214.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.0401788 | 68.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.0401879 | 138.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.0623134 | 35.33 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.0765354 | 213.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.841769 | 1096.6 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.8419624 | 56.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.8421893 | 950.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.8922051 | 784.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.8922657 | 947.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.935532 | 952.46 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9370178 | 691.74 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9473028 | 19.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9561873 | 239.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9759209 | 846.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9759497 | 931.87 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9764463 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 160.9896328 | 960.36 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0242169 | 251.98 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0242835 | 150.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0243762 | 55.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0458253 | 36.94 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0602414 | 269.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0708459 | 88.9 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.0816592 | 40.14 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8435405 | 950.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8439644 | 24.8 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8462599 | 345.61 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8465839 | 201.54 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8501968 | 1099.91 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8753717 | 22.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8924407 | 787.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.8926204 | 947.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9256502 | 19.81 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9256904 | 963.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9472409 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9473751 | 951.25 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9793404 | 949.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9871634 | 28.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 161.9922414 | 962.13 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.0224606 | 42.08 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.0225497 | 248.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.022692 | 138.47 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.0540134 | 41.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.0557174 | 167.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.0842686 | 40.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.838768 | 1098.41 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.8389729 | 53.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.8409996 | 950.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.87867 | 19.86 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.8929466 | 571.04 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.8931314 | 783.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.8931726 | 947.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.9318231 | 19.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.9319386 | 960.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.9532605 | 239.89 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.9826034 | 956.16 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 162.9892725 | 37.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.0251919 | 29.39 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 4-Coumarate | 163.039 | 2.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | m-Coumaric acid | 163.039 | 3.52 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 163.0398865 | 210.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.0401459 | 59.82 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.0606165 | 37.35 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.0761498 | 245.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.0762042 | 55.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8407776 | 24.5 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8414306 | 421.02 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8417236 | 254.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8438272 | 1077.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8556493 | 947.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8557473 | 19.76 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8721766 | 22.11 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8874883 | 36.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8875813 | 946.97 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.8877204 | 826.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.9121617 | 948.28 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.9295357 | 22.96 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.9407434 | 19.77 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.941095 | 967.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.9838307 | 37.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 163.986359 | 955.49 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Anthranilate/4-Aminobenzoate | 164.0346 | 3.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 164.0351992 | 185.12 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.0353557 | 38.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.0599477 | 24.42 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.0714098 | 181.64 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.0715272 | 37.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.0837361 | 241.45 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.8361921 | 42.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.8385359 | 950.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.8634315 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.86358 | 947.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.8952058 | 947.62 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.8954879 | 23.68 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.9266928 | 951.24 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.9274008 | 30.58 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 164.9569521 | 29.88 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0056488 | 957.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.01901 | 847.99 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0190443 | 296.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0192906 | 81.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0402735 | 710.21 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0403095 | 235.09 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0404569 | 617.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0405683 | 464.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0415901 | 26.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | Ethyl Paraben | 165.0542 | 4.56 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 3-(2-Hydroxyphenyl)Propanoate | 165.0548 | 3.44 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
| AN002193 | 165.0548977 | 77.71 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0551136 | 276.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0554355 | 173.75 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0916513 | 322 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.0918203 | 258.65 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.8377526 | 24.11 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.8509827 | 19.78 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.8513978 | 947.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.9025477 | 19.2 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.9026369 | 985.06 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.9286714 | 948.23 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.9394659 | 963.48 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 165.9933481 | 960.93 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0150914 | 268.3 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0166971 | 744.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0185068 | 25.69 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0188587 | 929.57 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0327328 | 210.59 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0415129 | 464.4 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.041665 | 617.55 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0434376 | 725.43 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine | |
| AN002193 | 166.0449011 | 25.83 | Minutes | ST001317 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Urine |
